Celltrion

Biosimilar makers split strategies in bid to take on top-selling Humira
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
Flag link:
7 companies are rolling out Humira biosimilars
7 companies are rolling out Humira biosimilars
Drugstore News
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Flag link:
Celltrion presents infliximab data at ECCO Congress
Celltrion presents infliximab data at ECCO Congress
Clinical Trials Arena
Celltrion
ECCO
infliximab
IBD
Flag link:
Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business
Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business
Fierce Pharma
Baxter
Thermofisher
Celltrion
M&A
CMOs
Flag link:
Celltrion's COVID-19 antibody improves outcomes in phase 2
Celltrion's COVID-19 antibody improves outcomes in phase 2
Fierce Biotech
Celltrion
COVID-19
antibodies
clinical trials
Flag link:
Corporate and regulatory developments over the holidays
Corporate and regulatory developments over the holidays
EP Vantage
AstraZeneca
Bristol-Myers Squibb
Celltrion
Cullinan Oncology
JNJ
Myovant Sciences
Osmotica Pharmaceuticals
Pfizer
Y-mAbs Therapeutics
United Therapeutics
Zai Lab
Flag link:
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment
Pharmaceutical Business Review
Celltrion
COVID-19
clinical trials
antivirals
Flag link:
Takeda continues post-Shire selloff, inching closer to $10B goal
Takeda continues post-Shire selloff, inching closer to $10B goal
Endpoints
Takeda
Celltrion
M&A
Shire
South Korea
Flag link:
Celltrion plans July COVID-19 trial, advances 'super antibody'
Celltrion plans July COVID-19 trial, advances 'super antibody'
Fierce Biotech
Celltrion
antibodies
COVID-19
clinical trials
Flag link:
Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis
Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis
Pharmaceutical Business Review
Celltrion
clinical trials
CT-P13
Crohn's Disease
ulcerative colitis
Flag link:
Celltrion plans to launch a biosimilar each year for next decade
Celltrion plans to launch a biosimilar each year for next decade
Pharmaforum
Celltrion
South Korea
biosimilars
JPMHC 2020
Flag link:
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
Flag link:
Celltrion taps Lonza to produce some of its Remicade biosimilar
Celltrion taps Lonza to produce some of its Remicade biosimilar
Biopharma Dive
Celltrion
Lonza
Remicade
biosimilars
Remsima
Flag link:
Celltrion and Samsung duel shaping up as both pledge billions of dollars to biologics
Celltrion and Samsung duel shaping up as both pledge billions of dollars to biologics
Fierce Pharma
biologics
South Korea
Celltrion
Samsung Bioepis
Flag link:
Celltrion, iProgen Biotech join forces to develop antibody-drug conjugates
Celltrion, iProgen Biotech join forces to develop antibody-drug conjugates
Pharmaceutical Business Review
Celltrion
iProgen Biotech
antibody-drug conjugate
Flag link:
FDA approves Celltrion's Herceptin biosimilar
FDA approves Celltrion's Herceptin biosimilar
BioCentury
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
Flag link:
FDA approves first biosimilar for NHL
FDA approves first biosimilar for NHL
BioCentury
Celltrion
Teva Pharmaceutical
non-Hodgkin's lymphoma
Truxima
biosimilars
rituximab
Flag link:
FDA panel unanimously backs Celltrion's Rituxan biosimilar
FDA panel unanimously backs Celltrion's Rituxan biosimilar
Fierce Pharma
Celltrion
Teva Pharmaceutical
biosimilars
Rituxan
FDA
advisory panels
Flag link:
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Celltrion
Roche
biosimilars
Rituxan
FDA
advisory panels
Flag link:
FDA panel to discuss Celltrion biosimilar
FDA panel to discuss Celltrion biosimilar
BioCentury
FDA
Rituxan/MabThera
biosimilars
CT-P10
Celltrion
Flag link:

Pages